ELENA MCGINTY: Open Payments
NPI 1386281533 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,235 in 196 payments from 18 companies in 2025. Trend: 2023 $7,325 · 2024 $5,537 · 2025 $9,235
Speaker / faculty: $5,500Food & beverage: $3,608Travel & lodging: $126
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $6,017 |
| Alkermes, Inc. | 41 | $798 |
| Neurocrine BioSciences, Inc. | 18 | $439 |
| Otsuka America Pharmaceutical, Inc. | 17 | $377 |
| E.R. Squibb & Sons, L.L.C. | 16 | $269 |
| Lundbeck LLC | 10 | $238 |
| Teva Pharmaceuticals USA, Inc. | 20 | $237 |
| Vanda Pharmaceuticals Inc. | 9 | $183 |
| Axsome Therapeutics, Inc. | 14 | $177 |
| Bausch Health US, LLC | 9 | $156 |
Products named: VRAYLAR, REXULTI, INGREZZA, ARISTADA, COBENFY, VIVITROL, AUSTEDO XR, Auvelity.
Industry payments across NC — which companies pay providers there.
